Bio News
Reed Waldman, co-founder and CEO of U.S.-based Veradermics, said the trend toward consumerization of medicine could spread beyond hair loss treatment to multiple conditions and products.
Veradermics secured promising data on its reformulated minoxidil candidate and increased the size of its initial public offering early this year.
CEO Waldman said GLP-1 drugs are driving the shift to a consumer-focused market.
Biobook Team
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
